Strattera

What is it?

Composition

The composition of Strattera includes the main active component - atomoxetine, which has a therapeutic effect in attention deficit hyperactivity disorder. Each capsule contains a certain dose of this substance, calculated depending on the needs of a particular patient. Excipients contribute to the stabilization and effective absorption of the main component.

• Atomoxetine: The main active ingredient that regulates norepinephrine levels in the brain.
• Cellulose: Used as a filler and stabilizer in capsules.
• Talc and magnesium stearate: Act as anti-caking agents, promoting even distribution of the drug.
• Gelatin: The capsule material that coats the active ingredients.

The combination of atomoxetine and other ingredients makes Strattera an effective choice for managing ADHD symptoms, providing patients with sustained improvements in concentration and compliance.

How to use?

Using Strattera requires following certain guidelines to ensure maximum effectiveness and minimize the risk of side effects. The drug is taken orally with a full glass of water. Although meals are not a requirement, it is recommended to take the medicine with food in case of stomach upset.

1. Take Strattera as directed by your doctor and strictly follow the instructions on the package.
2. When using multiple times a day, it is recommended to take the last dose several hours before bedtime to prevent sleep disturbances.
3. Continue taking the drug regularly and do not skip doses to achieve the expected therapeutic effect.
4. If you miss a dose, take it as soon as possible, but avoid taking a double dose if it is near the time of the next dose.

Following these guidelines will help achieve optimal results and minimize the likelihood of unwanted effects during the treatment of ADHD.

How does it work?

The mechanism of action of Strattera is based on the ability of atomoxetine to regulate the level of norepinephrine, an important neurotransmitter in the brain. Norepinephrine plays a key role in modulating attention and controlling impulsivity, which is very important for patients with ADHD. Strengthening the activity of this neurotransmitter leads to an improvement in cognitive functions, such as concentration and executive functions, which are usually impaired in such patients.

An important feature of Strattera is its non-specific stimulation, unlike other drugs for the treatment of ADHD, which makes it more suitable for some patients. The drug helps to normalize the chemical balance in the brain, which is especially important in chronic disorders such as ADHD.

Long-term use of Strattera helps to stabilize moods and behavior, which in turn improves the patients quality of life and facilitates his social adaptation. This is achieved due to the gradual accumulation of atomoxetine in the body and its long-term action.

Indications

Strattera is prescribed primarily for the treatment of attention deficit hyperactivity disorder, affecting both children and adults. The main goal of taking the drug is to improve attention and reduce hyperactivity, which is especially important for schoolchildren and students experiencing learning problems.

• Treatment of childhood and adult ADHD, which improves the educational process and communication with others.
• Improving concentration and reducing impulsivity in children over 6 years of age and adults.
• Long-term therapy for several weeks to achieve a sustainable clinical effect.

The basis for prescribing Strattera can be long-term observation and diagnosis by a specialist, which allows for a more accurate approach to the choice of therapy.

Contraindications

It is important to consider a number of contraindications when using Strattera, which should be discussed with your doctor. One of the most significant contraindications is the patients allergy to the components of the drug, which can provoke allergic reactions.

• Individual intolerance to atomoxetine or excipients.
• Certain cardiovascular diseases that can be aggravated by taking this drug.
• A diagnosis such as glaucoma is especially critical when interacting with Strattera.
• Depressive states or previously identified suicidal tendencies, requiring increased caution.

These contraindications must be taken into account and discussed with your doctor before starting therapy to avoid potential complications.

Side effects

When taking Strattera, there are some possible side effects that users should be aware of. Most of them are harmless, but some require a doctors consultation. This helps to adjust therapy in a timely manner and avoid serious health consequences.

• The appearance of headache, nausea, or dry mouth, which usually goes away over time or with dosage adjustments.
• The risk of drowsiness or dizziness, which can affect the ability to drive and operate machinery.
• Increased anxiety or irritability, requiring observation, especially in children.
• On the part of the digestive system, disorders such as diarrhea or constipation are possible.

If any of the listed effects persist for a long time or become significant, then you must seek medical help to adjust the therapy.